Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SOXN Activators

The biochemical activation mechanisms of SOXN involve a cascade of intracellular events triggered by various chemical activators. For instance, compounds that stimulate adenylyl cyclase result in a surge of cAMP levels, which in turn can augment SOXN transcriptional activity due to phosphorylation of CREB, a protein intimately involved in the regulation of gene expression. Similarly, when PKC is activated by certain molecules, it sets off a chain of downstream signaling that may culminate in the enhancement of SOXN activity, as PKC influences transcription factors that regulate gene expression, including those related to SOXN. Additionally, beta-adrenergic agonists work by increasing cAMP concentrations, thus potentially reinforcing SOXN activity via PKA signaling pathways, which are known to modulate the activity of key transcription factors.

Further contributing to the complexity of SOXN activation are compounds that affect intracellular calcium levels. Calcium ionophores, by increasing the cellular concentration of calcium ions, might indirectly stimulate SOXN through calcium-responsive signaling cascades, including calmodulin-dependent kinases, which are pivotal in regulating transcriptional processes. On another front, metabolic derivatives like retinoic acid have the capacity to regulate gene expression via their receptors, which could lead to enhanced SOXN activity by influencing transcriptional regulation. Additionally, the modulation of intracellular signaling by inhibiting certain kinases or by lithium-mediated inhibition of GSK-3, resulting in the activation of the Wnt signaling pathway, could also upregulate SOXN activity by affecting transcription factor function. Chromatin remodeling agents further enhance SOXN expression by increasing the accessibility of transcriptional machinery, while primary estrogens modulate gene expression and potentially promote SOXN activity through their receptors.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Activates protein kinase C (PKC), which can lead to downstream signaling pathways altering the activity of transcription factors that potentially increase SOXN activity.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Acts as a beta-adrenergic agonist elevating cAMP levels, thereby possibly enhancing SOXN activity through cAMP-dependent protein kinase A (PKA) signaling pathways.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

A non-specific inhibitor of phosphodiesterases that increases cAMP and cGMP levels, potentially enhancing SOXN activity through PKA and PKG pathways.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

A calcium ionophore raising intracellular calcium concentration, indirectly influencing SOXN activity through calcium-sensitive signaling pathways.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A calcium ionophore that can modulate intracellular calcium levels, affecting SOXN indirectly through calmodulin-dependent kinase pathways.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

A metabolite of vitamin A that regulates gene expression through retinoic acid receptors, potentially enhancing SOXN activity by influencing its transcriptional regulation.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

A cell-permeable cAMP analog that activates PKA, possibly leading to increased SOXN activity through phosphorylation of transcription factors.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Inhibits glycogen synthase kinase-3 (GSK-3), leading to the activation of Wnt signaling pathway, which may upregulate SOXN by influencing transcription factor activity.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

A histone deacetylase inhibitor that leads to chromatin remodeling, potentially enhancing SOXN expression by increasing accessibility of transcriptional machinery.

β-Estradiol

50-28-2sc-204431
sc-204431A
500 mg
5 g
$63.00
$182.00
8
(1)

A primary estrogen that through its receptor can modulate gene expression, potentially promoting SOXN activity by influencing transcriptional regulators.